Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M O Richard

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Effect of growth hormone on caffeine metabolism in hypophysectomized ratsT Bienvenu, G Pons, E Rey, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparationJ F Muir, G Peiffer, M O Richard, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administrationP Jaillon, J M Poirier, B Lecocq, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administrationE Rey, L Delaunay, G Pons, et al.
Developmental Pharmacology and Therapeutics|January 1, 1984
Pharmacokinetics of flunitrazepam after single rectal administration in childrenE Rey, M Nandakumaran, M O Richard, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics of oral cyclosporin A in diabetic children and adolescentsC Misteli, E Rey, G Pons, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjectsE Rey, H D El-Assaf, M O Richard, et al.
Therapeutic Drug Monitoring|July 1, 1990
Intravenous lidocaine in the treatment of convulsions in the neonatal period: monitoring plasma levelsE Rey, M F Radvanyi-Bouvet, C Bodiou, et al.
Therapie|July 1, 1981
[Comparative bioavailability of two forms of spironolactone. Rationalization applied to dosage (author's transl)]P d'Athis, M O Richard, D de Lauture, et al.
Developmental Pharmacology and Therapeutics|January 1, 1988
Developmental changes of caffeine elimination in infancyG Pons, O Carrier, M O Richard, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Effect of growth hormone on caffeine metabolism in hypophysectomized ratsT Bienvenu, G Pons, E Rey, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparationJ F Muir, G Peiffer, M O Richard, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administrationP Jaillon, J M Poirier, B Lecocq, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administrationE Rey, L Delaunay, G Pons, et al.
Developmental Pharmacology and Therapeutics|January 1, 1984
Pharmacokinetics of flunitrazepam after single rectal administration in childrenE Rey, M Nandakumaran, M O Richard, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics of oral cyclosporin A in diabetic children and adolescentsC Misteli, E Rey, G Pons, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjectsE Rey, H D El-Assaf, M O Richard, et al.
Therapeutic Drug Monitoring|July 1, 1990
Intravenous lidocaine in the treatment of convulsions in the neonatal period: monitoring plasma levelsE Rey, M F Radvanyi-Bouvet, C Bodiou, et al.
Therapie|July 1, 1981
[Comparative bioavailability of two forms of spironolactone. Rationalization applied to dosage (author's transl)]P d'Athis, M O Richard, D de Lauture, et al.
Developmental Pharmacology and Therapeutics|January 1, 1988
Developmental changes of caffeine elimination in infancyG Pons, O Carrier, M O Richard, et al.
Pageof 6